2367 logo

Giant Biogene Holding Co., Ltd. Stock Price

SEHK:2367 Community·HK$29.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

2367 Share Price Performance

HK$27.38
-33.82 (-55.26%)
HK$27.38
-33.82 (-55.26%)
Price HK$27.38

2367 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

2 Risks
2 Rewards

Giant Biogene Holding Co., Ltd. Key Details

CN¥5.5b

Revenue

CN¥1.1b

Cost of Revenue

CN¥4.4b

Gross Profit

CN¥2.5b

Other Expenses

CN¥1.9b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.80
80.34%
34.70%
0%
View Full Analysis

About 2367

Founded
2000
Employees
2201
CEO
Jianya Yan
WebsiteView website
www.xajuzi.com

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It offers functional skincare products, medical dressings and devices, and functional food products under the KOMFYMED, Collgene, Ke Yu, SKIGIN, and other brands. The company also develops and manufactures rare ginsenosides technology-based functional food products. In addition, it provides aesthetic services. The company was founded in 2000 and is headquartered in Xi'an, the People’s Republic of China.

Recent 2367 News & Updates

Recent updates

No updates